{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"}],"description":"Number of Participants with Adverse Events related to study treatment","groups":[{"description":"Participants who received NYESO-1ᶜ²⁵⁹T following ASCT","id":"OG000","title":"NYESO-1ᶜ²⁵⁹T Cells"}],"paramType":"NUMBER","populationDescription":"Participants who received NYESO-1ᶜ²⁵⁹T following ASCT","reportingStatus":"POSTED","timeFrame":"Day -40 to Year 1 post-treatment","title":"Adverse Events Related to Study Treatment","type":"PRIMARY","unitOfMeasure":"participants"}